# Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes

> **NCT00123604** · PHASE4 · COMPLETED · sponsor: **St. Paul Heart Clinic** · enrollment: 36 (actual)

## Conditions studied

- Hypertension
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT00123604
- **Lead sponsor:** St. Paul Heart Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123604, "Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00123604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*